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Abstract 
Accumulating evidence has shown that miRNAs are aberrantly expressed in human gastric 
cancer and crucial to tumorigenesis. Herein, we identified the role of miR-148a in gastric cell 
proliferation. miR-148a knockdown inhibited cell proliferation in gastric cancer cell lines. 
Conversely, miR-148a overexpression promoted cell proliferation and cell cycle progression. 
p27, a key inhibitor of cell cycle, was verified as the target of miR-148a, indicating miR-148a 
might downregulate p27 expression to promote gastric cell proliferation. Moreover, we 
confirmed that miR-148a expression was frequently and dramatically downregulated in human 
advanced gastric cancer tissues, and observed a good inverse correlation between miR-148a 
and  p27  expression  in  tumor  samples.  Thus,  our  results  demonstrated  that  miR-148a 
downregulation might exert some sort of antagonistic function in cell proliferation, rather 
than promote cell proliferation in gastric cancer. 
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Introduction 
Gastric  cancer  remains  one  of  the  most  fre-
quently occurring malignancies, and ranks as the se-
cond leading cause of mortality next to lung cancer 
[1]. Although alterations in a large number of onco-
genes  and  tumor  suppressor  genes  have  been  re-
ported  in  gastric  carcinomas  [2],  the  molecular 
mechanisms  underlying  the  pathogenesis  of  gastric 
carcinomas remain to be fully defined. 
miRNAs  are  small,  noncoding,  single-stranded 
RNAs that bind to complementary sequences in the 3’ 
untranslated region (UTR) of their target mRNAs and 
induce mRNA degradation or translational repression 
[3].  miRNAs  are  involved  in  various  cell  functions, 
including proliferation, differentiation and apoptosis. 
Characteristic miRNA signatures have been identified 
for human gastric cancer, which predict disease status 
and  clinical  outcome  [4-9].  Among  them,  miR-148a 
was  one  of  the  most  frequently  downregulated 
miRNAs in miRNA profiles of gastric cancers [4, 7, 8], 




sis  [7].  Previous  studies  have  shown  that  miR-148a 
plays important roles in cancer cell proliferation, re-
sponse to anti-cancer chemotherapy, and metastasis 
in some tumor types including cholangiocarcinoma, 
prostate,  esophageal  and  colon  cancers  [10-15].  For 
instance,  downregulation  of  cytokine  interleu-
kin-6-regualted miR-148a contributes to cell prolifer-
ation  by its  target  DNMT1  in  malignant  cholangio-
cytes  [10].  In  prostate  cancer  PC3  cells,  miR-148a 
could  inhibit  cell  proliferation,  migration  and  inva-
sion, and increase the sensitivity to anti-cancer drug 
[11]. However, the functional roles and target genes of 
miR-148a in gastric cancer remain unknown. 
In  this  study,  we  investigated  the  role  of 
miR-148a in cell proliferation of gastric cancer cells. 
Unexpectedly, inhibition of miR-148a expression re-
pressed cell proliferation in gastric cancer cell lines. 
Conversely,  transient  and  stable  overexpression  of 
miR-148a  promoted  cell  proliferation  and  cell  cycle 
progression.  Moreover,  p27,  a  key  inhibitor  of  cell 
cycle, was identified as the direct target of miR-148a, 
suggesting  that  miR-148a  might  exert  its  function 
through the downregulation of p27. Finally, we con-
firmed  that  miR-148a  expression  was  frequently 
downregulated  in  human  advanced  gastric  cancer 
tissues, and observed a good inverse correlation be-
tween  miR-148a  and  p27  expression  in  tumor  sam-
ples.  Taken  together,  our  findings  suggested  that 
miR-148a  downregulation  might  exert  antagonistic 
function  in  gastric  cancer  cell  proliferation  during 
gastric tumorigenesis.   
Results and Discussion 
To explore the tissue-specific expression pattern 
of miR-148a, we detected miR-148a expression in dif-
ferent tissues  of mouse  by Northern blot. miR-148a 
expression was relatively high in stomach, heart, in-
testine, colon and liver (Fig. 1A). To visualize the spa-
tial localization of miR-148a in whole-stomach tissue 
of mouse, we applied locked nucleic acid in situ hy-
bridization. Unlike with the mismatch control probe 
(scrambled  miRNA),  hybridization  with 
miR-148a-specific probe revealed that miR-148a was 
expressed at the bottom half of glandular gastric epi-





Figure 1: Tissue-specific and cell-specific expression pattern of miR-148a in mouse (A), miR-148a expression was detected 
in various tissues of mouse by Northern blot. (B), ISH analysis showed that miR-148a expression was located at bottom half 





Figure  2: miR-148a promoted cell proliferation in gastric cancer cells. (A), miR-148a expression was measured by 
Northern blot in 6 human gastric cancer cell lines. (B), miR-148a downregulation with AS was confirmed by Northern Blot 
in a representative transfectant. (C), miR-148a downregulation inhibited cell proliferation in AGS, BGC-823 and SGC-7901 
cells. Gastric cancer cells were transfected with miR-148a AS or scrambled miRNA AS (as a negative-control, NC AS). Cell 
viability was determined by cell count 72 and 96 hours after transfection. The numbers of viable cells transfected with NC 
AS were set at 1. (D), miR-148a promoted cell proliferation in AGS cells. miR-148a overexpression with mimic were 
confirmed by Northern Blot in AGS cells. Cell viability was determined by cell count 72 and 96 hours after transfection. (E), 
Northern blot revealed that miR-148a expression was increased in stably miR-148a-expressing AGS cells (miR-148a) 
compared with AGS stably transfected with empty vector (vector). Cell count showed that the cell numbers at 48 and 72 
hours were increased in stably miR-148a-expressing AGS cells. (F), Cell cycle analysis showed that AGS cells transiently 
transfected with miR-148a mimic exhibited increased population of cells at S phase 24 hours after transfection. (G), Stably 
miR-148a-expressing AGS cells (AGS-miR-148a) also showed increased population of cells at S phase. (H), FCAS analysis 
showed no obvious change was observed in apoptosis induced by Etoposide. Values represent mean ± SD. n=3. *P<0.05, 
**P<0.01. 




Several  independent  lines  of  evidence  have 
shown that miR-148a was one of the most frequently 
downregulated  microRNAs  in  human  gastric  carci-
nomas [4, 7, 8]. These studies led us to speculate that 
miR-148a  dowregulation  could  contribute  to  gastric 
cell proliferation. We first detected miR-148a expres-
sion in 6 human gastric cancer cell lines. Northern blot 
results  showed  that  miR-148a  expression  in  AGS, 
BGC-823  and  SGC-7901  cells  was  relatively  higher 
than that in GES-1, BGC-803 and SNU-16 cells (Fig. 
2A). Next, to evaluate the role of miR-148a downreg-
ulation  in  gastric  cancer  cells,  we  engineered 
miR-148a with antisense oligonucleotides (miR-148a 
AS) to decrease the endogenous miR-148a expression 
in 3 human gastric cancer cell lines, AGS, BGC-823 
and  SGC-7901,  respectively.  The  downregulation  of 
miR-148a were confirmed by Northern Blot (Fig. 2B). 
Cellular proliferation assays were performed on the 
miR-148a-AS-tranfected  cells.  To  our  surprise, 
miR-148a  knockdown inhibited  cell  proliferation  by 
20-40%  after  96  hours  in  AGS,  BGC-823,  and 
SGC-7901 cells (Fig. 2C, p<0.05). 
To substantiate the function of miR-148a in gas-
tric cell proliferation, we transfected AGS cells with 
miR-148a  mimic.  Northern  Blot  confirmed  the  in-
creased  expression  of  miR-148a  in  the  transfectant 
(Fig. 2D). Viable cell numbers were counted at 72 and 
96 hours after transfection. Consistent with our pre-
diction, the cell numbers of miR-148a-transfected AGS 
cells at 72 and 96 hours were found to be increased by 
42%  and  48%,  respectively,  compared  with  that  of 
scrambled-miRNA-transfected cells (Fig. 2D, p<0.05). 
Moreover,  we  established  a  stable  cell  line 
(AGS-miR-148a)  in  which  miR-148a  expression  was 
significantly  higher  than  that  in  AGS  stably  trans-
fected  with  empty  vector  (AGS-vector)  (Fig.  2E). 
Consistently, the cell numbers of AGS-miR-148a at 48 
and  72  hours  were  increased  by  18%  and  30%,  re-
spectively, compared with that in control cells (Fig. 
2E, p<0.05).  
It  is  known  that  abnormal  cell  proliferation  is 
related to the altered cell cycle. Cell cycle analysis was 
conducted in AGS cells transiently transfected with 
miR-148a mimic. The proportion of cells correspond-
ing  to  S  phase  was  higher  in  miR-148a-transfected 
AGS (34%±2.9%) than that in control cells (26%±2.1%, 
p<0.05, Fig. 2F). Similar results were obtained in the 
stable miR-148a-expressing AGS cells (Fig. 2G). These 
data suggested that miR-148a could promote cell pro-
liferation  by  increasing  the  population  of  cells  in  S 
phase. In addition, we checked the effect of miR-148a 
on apoptosis by FACS analysis, and no obvious dif-
ferences were observed between miR-148a-tansfected 
AGS cells and control cells (Fig. 2H). 
To  determine  the  mechanisms  by  which 
miR-148a  promotes  gastric  cell  proliferation,  bioin-
formatics  analysis  was  performed  to  search  for 
miR-148a  targets.  CDNK1B  (encoding  p27),  a  gene 
critical for cell cycle [15], was predicted as a putative 
target of miR-148a (Fig. 3A). p27 mRNA 3’UTR has a 
single predicted binding site that is highly conserved 
in mammals, and in chicken (Fig. 3A). To determine 
whether  miR-148a  could  directly  regulate  p27,  p27 
mRNA  3’UTR  encompassing  the  predicted  binding 
site  with  or  without  mutation  that  would  disrupt 
miRNA interaction (underlined in Fig. 3A), were in-
serted to the downstream of luciferase open reading 
frame in pGL3-CM reporter vector. When introduced 
into SGC-7901 cells, the wild type p27 3’UTR reporter 
showed a 39% reduction in luciferase activity in the 
miR-148a-transfected  cells  compared  with  that  in 
scrambled-miRNA-transfected cells (Fig. 3B, p<0.01). 
Mutation of miR-148a binding site abrogated the re-
pression  of  luciferase  activity  caused  by  miR-148a 
overexpression (Fig. 3B). Next, we pursued the ability 
of  miR-148a  to  regulate  the  expression  of  en-
dongenous p27. miR-148a overexpression with mimic 
in  AGS  cells  dramatically  repressed  p27  expression 
(Fig.  3C).  Conversely,  miR-148a  knockdown  by  AS 
dramatically  enhanced  p27  expression  in  BGC-823 
cells (Fig. 3C), indicating that endogenous miR-148a 
could regulate p27 abundance. To examine the func-
tional  interrelationship  between  miR-148a  and  p27, 
AGS  cells  was  simultaneously  transfected  with 
miR-148a  mimic  and  p27-expressing  vector 
(CMV-p27). As expected, overexpression of p27 dra-
matically rescued miR-148a-induced growth promo-
tion  (Fig.  3D,  p<0.01),  indicating  that  miR-148a  en-
hanced cell proliferation possibly by repressing p27. 
Finally, we detected the expression of miR-148a 
and p27 in 10 advanced gastric primary tumors, each 
one paired with adjacent nontumor gastric tissue from 
the same patient (Fig. 4A and 4C). Northern blot as-
says showed that the reduced expression of miR-148a 
was found in 100% (10/10) of human advanced gas-
tric tumor tissues as compared with adjacent normal 
counterparts (Fig. 4A and 4B, p=0.005), indicating that 
miR-148a downregulation was a very common event 
in advanced gastric cancer. Furthermore, the inverse 
correlation was observed between miR-148a and p27 
in tumor samples (r=0.648, Fig. 4D), suggesting that 
miR-148a could negatively regulate p27 expression in 
human gastric cancer. 
Previous  studies  have  shown  that  miR-148a 
could target its distinct targets to regulate cell prolif-
eration in some cancer cells [10,12,16]. DNMT1, a di-
rect target of miR-148a, plays important role to sup-




[10]. miR-148a, also targets and suppresses Microph-
thalmia associated transcription factor (Mitf), an im-
portant regulator involved in melanoma progression 
[16]. In the present study, we identified a new target, 
p27, possibly by which miR-148a could promote cell 
cycle  progression  and  cell  proliferation.  Similarly, 
miR-148a could promote cell growth by repressing its 
target CAND1 expression in prostate cancer LNCaP 
cells [12]. These findings indicated that the different 
roles  of  miR-148a  in  regulating  cell  proliferation 
might depend on its distinct targets in different tumor 
cell  types.  miR-148b,  which  has  the same “seed se-
quence” as miR-148a, was downregulated in gastric 
cancer, and could inhibit cell proliferation by target-
ing CCKBR [17]. Although CCKBR was a predicted 
target of miR-148a by bioinformatic analysis, it was 
not a real target of miR-148a by Western blot and lu-
ciferase  reporter  assay  in  our  experimental  system 
(data  not  shown),  indicating  that  miR-148a  and 
miR-148b,  both  belonging  to  the  same  microRNA 
family,  might  exert  opposite  roles  in  one  cell  type 




Figure 3: p27 was a direct target of miR-148a in gastric cancer cells. (A), The possible miR-148a binding site in CDNK1B 
(p27) mRNA 3’UTR was predicted by bioinformatic analyses. The mutant seed sequence was underlined. p27 had a single 
predicted binding site in mRNA 3’UTR that was highly conserved in mammals, and in chicken (the complementary sequences 
of seed sequence of miR-148a were highlighted). (B), Luciferase activities were measured in SGC-7901 cells cotransfected 
with the reporter constructs containing 3’UTR of p27 with or without mutant (underlined in A) and miR-148a mimic or 
negative-control miRNA. (C), Western blot assays confirmed that p27 expression were downregulated by miR-148a mimic 
in  AGS  cells  and  upregulated  by  miR-148a  AS  in  BGC-823  cells.  (D),  p27  expression  was  significantly  increased  in 
p27-transfected AGC cells (CMV-HA-p27) compared with that in control cells (CMV-HA). The numbers of viable AGS cells 
were determined by cell count 72 hours after cotransfection with miR-148a mimic and CMV-HA-p27 vector. Values rep-
resent mean ± SD. n=3. **P<0.01 





Figure 4: miR-148a was frequently and dramatically downregulated in human advanced gastric cancer and showed an 
inverse correlation with p27 expression in tumor samples. (A), miR-148a expression was determined by Northern blot in 
10 advanced gastric primary tumors, each one paired with adjacent nontumor gastric tissue from the same patient. (B), 
Statistically significant downregulation of miR-148a in gastric cancers over matching normal tissues. P=0.005 by Wilcoxon 
signed rank test. Bars represent mean. (C), p27 expression was examined by Western blot in the same samples. (D), The 





In  this  study,  we  observed  that  miR-148a  was 
frequently downregulated in human advanced gastric 
cancer  samples.  We  also  showed  that  inhibition  of 
miR-148a  suppressed  cell  proliferation  in  different 
gastric cancer cell lines possibly by upregulating its 
target p27, suggesting that miR-148a downregulation 
in human gastric cancer might inhibit but not promote 
gastric cancer cell proliferation during gastric tumor-
igenesis. Some evidence has shown that miR-148a is 
associated  with  migration,  metastasis,  and  drug  re-
sistance in some tumor types [7,11,13,14], indicating 
that  miR-148a  downregulation  might  contribute  to 
these biological processes in gastric cancer. In fact, we 
also found that miR-148a overexpression with mimic 
could promote gastric cell migration (Fig. S1, p<0.05).  
Conclusion  
In  this  study,  we  investigated  the  role  of 
miR-148a  in  regulating  cell  proliferation  of  gastric 
cancer cells. We  observed that miR-148a expression 
was  frequently  and  dramatically  downregulated  in 
human  advanced  gastric  cancer  tissues  compared 
with  the  matched  adjacent  normal  tissues.  Unex-
pectedly, miR-148a knockdown inhibited cell prolif-
eration in gastric cancer cell lines. We further showed 
that transient and stable overexpression of miR-148a 
could  promote  cell  proliferation  and  cell  cycle  pro-
gression. Moreover, p27, a key inhibitor of cell cycle, 
was verified as a direct target of miR-148a, suggesting 
that miR-148a might promote gastric cell proliferation 
by depressing p27 expression. Collectively, our find-




exert  some  sort  of  antagonistic  function  in  gastric 
cancer cell proliferation during gastric tumorigenesis.  
Methods 
Human gastric tissues. Paired gastric cancer and 
adjacent non-tumor gastric tissues were obtained after 
review  and  approval  by  the  General  Surgery  De-
partment  of  PLA  General  Hospital  of  China.  Both 
tumor and non-tumor tissues were histologically con-
firmed.  Informed  consent  was  obtained  from  each 
patient before operation. Tissue samples were imme-
diately frozen in liquid nitrogen until RNA extraction.  
Cell culture and transfection. The gastric cancer cell 
lines AGS,  GES-1, SNU-16,  MGC-803, BGC-823 and 
SGC-7901 were cultured in Dulbecco's Modified Eagle 
Medium  supplemented  with  2mM  L-glutamine,  1% 
penicillin/streptomycin, and 10% fetal bovine serum 
(Hyclone)  at 37℃ and  5%  CO2.  AGS,  BGC-823  and 
SGC-7901 cells were individually plated onto tissue 
culture plates or dishes 24 hours before transfection. 
Transient transfection of miRNA mimics or anti-sense 
(AS) and control oligonucleotides (Genepharm) at a 
final concentration of 50 nM was accomplished with 
lipofectmine  2000  reagent  (Invitrogen).  To  establish 
stably transfected AGS, pIRES2-EGFP vector (BD Bi-
oscience) was inserted with 164bp genomic sequence 
of miR-148a precursor. The primers for PCR amplifi-
cation  are:  sense,  5’-  AAAAGATCTGA 
ACACACCTGCAGGAAGAA-3’,  anti-sense,  5’- 
AAAAAAGCTTCTGGCGTCTGGAGCACTG-3’.  Sta-
bly  transfected  cells  were  selected  using  G418 
(500μg/ml, Gibco). 
Cell cycle analysis. Cells were harvested and pro-
cessed by standard methods by using propidium io-
dide  staining  of  cell  DNA.  Cell  samples  were  ana-
lyzed with a FACScan flow cytometer (BD Bioscienc-
es).  Histograms  were  analyzed  for  cell  cycle  com-
partments using ModFit version 2.0 (Verity Software 
House).  
Proliferation assays. 2×104 Cells were seeded into 
24-well plate in triplicate, and the cell number was 
counted  48,  72  or  96  hours  later  under  microscope 
using a hemocytometer.  
Apoptosis  assay.  AGS  cells  were  treated  with 
etoposide  (30μg/ml)  or  a  matched  concentration  of 
diluents for 48 hours. After the treatment, cells were 
rinsed  twice  in  cold  PBS,  and  then  analyzed  for 
apoptosis by a PE-labeled Annexin-V/7-AAD assay. 
Cell  samples  (10,000  events)  were  analysed  in  a 
FACScan flow cytometer (BD Biosciences), and data 
were processed using FACScan software. 
Luciferase  activity  assay.  The  3’UTR  region  of 
human  p27  mRNA  that  containing  miR-148a  target 
site was amplified using specific primers: sense, 5’- 
CCGCTCGAGGTTTATCAGATACATCACTGCTTG
A-3’,  anti-sense,  5’-  CCGACGCGTTTGGCTC 
AGTATGCAACCTTTT-3’, and cloned into pGL3-CM 
to  generate  luciferase  reporter  vector.  The  mutant 
vector of p27 3′UTR was also constructed. The method 
for luciferase assay was described previously [18]. In 
brief, reporter vectors were co-transfected with renilla 
luciferase expressing vector to normalize transfection 
efficiency. Luciferase activity assays were done at 48 
hours  after  transfection  using  a  Dural-luciferase® 
reporter assay system (promega) using LB 960 Centro 
XS3 luminometer (Berthold Technologies). 
Northern  blot.  Northern  blot  analysis  was  per-
formed as described using 20 μg total RNA from each 
sample [18]. Probes were labeled with 32P γ-ATP us-
ing T4 polynucleotide kinase (New England Biolabs).  
miRNA in situ hybridization. miRNA in situ hy-
bridization  was  performed  as  previously  described 
[19] using locked nucleic acid (LNA) probes comple-
mentary  to  mouse  mature  miR-148a  (Exiqon)  or 
scrambled  control  sequence  (Exiqon).  LNA  probes 
were hybridized to mouse gastric tissue at 60°C. 
Western  blot.  Cells  were  homogenized  in  lysis 
buffer supplemented with protease inhibitor cocktail 
(Roche).  Proteins  (25  ug)  were  electrophoresed  on 
SDS-PAGE and  transferred  onto  PVDF  membranes. 
Immunoblotting  was  done  using  human  p27  (Cell 
Signaling) and GAPDH (ZSGB-Bio) antibodys. 
Statistical analysis. All values were expressed as 
mean±SD.  Statistical  analysis  was  performed  by 
2-tailed Student’s t test, and results were considered 
statistically significant at P < 0.05. Wilcoxon signed 
rank test was used to analyze the statistically signifi-
cant downregulation of miR-148a expression in gas-
tric cancers. Correlation coefficient was calculated by 
Spearman rank correlation analysis. 
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Figure  S1: miR-148a  promoted  gastric  cell  migration  in  AGS  cells.  Scratch  wound-healing  assay  was  conducted in 
miR-148a-transfected AGS cells and control cells. Migration distance was measured at 0, 24, 48 hours after cells were 
scratched. Values represent mean ± SD. n=3. *P<0.05. 
 